US 10828250
Topical formulation
granted A61KA61K31/07A61K31/192
Quick answer
US patent 10828250 (Topical formulation) held by LIMEWAY PHARMA DESIGN LIMITED expires Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- LIMEWAY PHARMA DESIGN LIMITED
- Grant date
- Tue Nov 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61K, A61K31/07, A61K31/192, A61K31/203, A61K31/232